The influence of angiotensin-converting enzyme inhibition on renal tubular function in progressive chronic nephropathy

American Journal of Kidney Diseases

Volumn 28, Issue 6, 1996, Pages 822-831

  Kamper, Anne Lise ^a   Holstein Rathlou, Niels Henrik ^b   Leyssac, Paul Peter ^b   Strandgaard, Svend ^b  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

Angiotensin converting enzyme inhibition; chronic nephropathy; enalapril; lithium clearance; potassium clearance; progression of uremia; proteinuria; renal tubular function; sodium clearance

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IMMUNOGLOBULIN G; LITHIUM; POTASSIUM; RETINOL BINDING PROTEIN; SODIUM;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; FEMALE; HUMAN; KIDNEY CLEARANCE; KIDNEY TUBULE FUNCTION; MAJOR CLINICAL STUDY; MALE; POTASSIUM EXCRETION; PROTEINURIA; SODIUM EXCRETION;

EID: 0029802344     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90381-9     Document Type: Article

References (34)

1. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
2. Meyer TW, Anderson S, Rennke HG, Brenner BM: Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 31:752-759, 1987
3. Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa I: Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 82:322-330, 1988
4. Remuzzi A, Puntorieri S, Battaglia C, Bertani C, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85:541-549, 1990
5. Lafayette RA, Mayer G, Park SG, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90:766-771, 1992
6. Björck S, Mulec H, Johnsen SA, Nordén G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. BMJ 304:339-343, 1992
7. Kamper A-L, Strandgaard S, Leyssac PP: Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial. Am J Hypertens 5:423-430, 1992
8. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
9. Becker GJ, Whitworth JA, Ihle BU, Shahinfar S, Kincaid-Smith PS: Prevention of progression in non-diabetic chronic renal failure. Kidney Int 45:S-167-170, 1994
10. Hannedouche T, Landais P, Goldfarb B, El Esper N, Founder A, Godin M, Durand D, Chanard J, Mignon F, Suc J-M, Grünfeld J-P: Randomised controlled trial of enalapril and blockers in non-diabetic chronic renal failure. BMJ 309:833-837, 1994
11. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zucchelli P, and the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group: Effect of the angiotensinconverting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996
12. Leyssac PP, Karlsen FM, Skøtt O: Dynamics of intrarenal pressures and glomerular filtration rate after acetazolamide. Am J Physiol 261:169-178, 1991
13. Leyssac PP, Karlsen FM, Holstein-Rathlou N-H, Skøtt O: On determinants of glomerular filtration rate after inhibition of proximal tubular reabsorption. Am J Physiol 266:R1544-1550, 1994
14. Harris DCH, Chan L, Schrier RW: Remnant kidney hypermetabolism and progression of chronic renal failure. Am J Physiol 254:F267-276, 1988
15. Shapiro JI, Harris DCH, Schrier RW, Chan L: Attenuation of hypermetabolism by dietary phosphate restriction in the rat. Am J Physiol 258:F183-188, 1990
16. Risdon RA, Sloper JC, de Wardener HE: Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 2:363-366, 1968
17. Lane PH, Steffes MW, Fioretto P, Mauer SM: Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 43:661-667, 1993
18. Ishidoya S, Morrissey J, McCracken R, Klahr S: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 49:1110-1119, 1996
19. Kamper A-L, Holstein-Rathlou N-H, Leyssac PP, Strandgaard S: Lithium clearance in chronic nephropathy. Clin Sci 77:311-318, 1989
20. Hemmingsen L, Skaarup P: The 24-hour excretion of plasma proteins in the urine from apparently healthy subjects. Scand J Clin Lab Invest 35:347-353, 1975
21. Holm J, Hemmingsen L, Nielsen NV, Thomsen M: Urinary excretion of the retinol binding protein in insulin-dependent diabetic patients as an index of tubular dysfunction. IRCS Med Sci 14:1205-1206, 1986
22. Thomsen K: Lithium clearance: A new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 37:217-223, 1984
23. Boer WH, Fransen R, Shirley DG, Walter SJ, Boer P, Koomans HA: Evaluation of the lithium clearance method: Direct analysis of tubular lithium handling by micropuncture. Kidney Int 47:1023-1030, 1995
24. Shirley DG, Singer DRJ, Sagnella GA, Buckley MG, Miller MA, Markandu ND, MacGregor GA: Effect of a single test dose of lithium carbonate on sodium and potassium excretion in man. Clin Sci 81:59-63, 1991
25. Malnic G, Klose RM, Giebisch G: Micropuncture study of distal tubular potassium and sodium transport in rat nephron. Am J Physiol 211:529-547, 1966
26. Harris PJ, Young JA: Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney. Pflugers Arch 367:295-297, 1977
27. Schuster VL, Kokko JP, Jacobson HR: Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Invest 73:507-515, 1984
28. Braam B, Mitchell KD, Fox J, Navar LG: Proximal tubular secretion of angiotensin II in rats. Am J Physiol 264:F891-898, 1993
29. Seikaly MG, Arant BS, Senney FD: Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86:1352-1357, 1990
30. Siragy HM, Howell NL, Ragsdale V, Carey RM: Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension 25:1021-1024, 1995
31. Hannedouche T, Delgado A, Gnionsahe A, Lacour B, Grünfeld JP: Influence of captopril on renal hemodynamics and segmental tubular reabsorption of sodium in humans. J Cardiovasc Pharmacol 13:84-89, 1989
32. Vos PF, Boer P, Koomans HA: Effects of enalapril on renal sodium handling in healthy subjects on low, intermediate, and high sodium intake. J Cardiovasc Pharmacol 22:27-32, 1993
33. Hannedouche TP, Delgado AG, Gnionsahe DA, Boitard C, Lacour B, Grünfeld JP: Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes. Kidney Int 37:1125-1133, 1990
34. Holdaas H, Hartman A, Lien MG, Nielsen L, Jervell J, Fauchald P, Endresen L, Djøseland O, Berg KJ: Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. J Int Med 229:163-170, 1991